Search Menu
People

Dr Elaina Collie-Duguid

Dr Elaina Collie-Duguid
Dr Elaina Collie-Duguid
Dr Elaina Collie-Duguid

BSc (Hons) (First Class, Brisbane, Australia, 1990), PhD (Aberdeen, 1997)

Manager, Centre for Genome Enabled Biology & Medicine

About
Email Address
e.collie-duguid@abdn.ac.uk
Telephone Number
+44 (0)1224 437958
Office Address

School of Medicine, Medical Sciences and Nutrition. Room 4.015. Polwarth Bulding. Foresterhill. Aberdeen. AB25 2ZD

and

Centre for Genome Enabled Biology and Medicine. Room G17. 23 St Machar Drive. Old Aberdeen. Aberdeen. AB24 3RY.

 

School/Department
School of Medicine, Medical Sciences and Nutrition

Biography

Elaina Collie-Duguid was awarded a first class BSc (Hons) degree in molecular biology from the University of Queensland, Brisbane, Australia in 1990. Her time as a research assistant at the Centre for Molecular Biology and Biotechnology (currently The Institute of Molecular Bioscience), University of Queensland, was followed by a period of international travel, culminating in a move to Aberdeen in 1993 to begin a PhD in molecular and cellular biology at the Rowett Research Institute. In 1996, Dr Collie-Duguid took up post as a post-doctoral scientist in the Department of Medicine and Therapeutics at the University of Aberdeen and she now heads a Cancer Medicine research group with a particular focus on breast cancer within the Cancer Biomedicine programme.

Dr Collie-Duguid manages the Centre for Genome Enabled Biology and Medicine (CGEBM) at the University of Aberdeen. CGEBM provides strategic direction and coordinated management of the University of Aberdeen’s genomics facilities and facilitates genomics enabled interdisciplinary research by provision of specialised expertise, infrastructure, training, a focal point for collaboration and information exchange and genomics services to the research community. CGEBM provides specialist services in next generation sequencing (NGS), microarrays, bioinformatics and biostatistics. CGEBM helps to drive genome focused research forward by developing and exploiting modern genomic technologies to accelerate discovery of novel approaches to improve human health, the environment and agriculture within the diverse programmes of applied translational, clinical, biomedical and biological research at the University of Aberdeen.

 

 

External Memberships

Scientific Member of the Experimental and Translational Medicine Research Committee of the Chief Scientist Office, 2009-2014

Scientific Member of the Biomedical and Therapeutics Research Committee of the Chief Scientist Office, 2005-2009.

Research

Research Overview

Dr Collie-Duguid's research interest is to understand the molecular and cellular mechanisms controlling tumorigenesis, survival of cancer patients and chemoresistance in solid tumours, with a particular focus on breast cancers.  Biomarker discovery for prediction of clinical outcomes, including response to therapy; and novel drug target identification for drug development are key elements of her translational research programme. Dr Collie-Duguid has an interest in using genomic tools to understand human disease and important biological processes.

Teaching

Teaching Responsibilities

Dr Collie-Duguid teaches on level 5 courses MB5021 Bioinformatics, MT5003 Drug Metabolism and Toxicology, and MT5515 Research Methods, level 4 PA4302 Molecular Toxicology, level 3 PA3802 Mechanisms of Disease and Principles of Chemotherapy and Intercalated BSc MB ChB teaching in Genetic variation and Bioinformatics, and provides research project supervision to level 5 MSc students in the field of genomics.  

Publications

Page 1 of 1 Results 1 to 63 of 63

  • Venomous gland transcriptome and venom proteomic analysis of the scorpion Androctonus amoreuxi reveal new peptides with anti-SARS-CoV-2 activity. Peptides

    Ghazal, A., Clarke, D. J., Abdel-Rahman, M. A., Ribeiro, A., Collie-Duguid, E., Pattinson, C., Burgoyne, K., Muhammad, T., Alfadhel, S. M., Heidari, Z., Samir, R., Gerges, M., Nkene, I., Colamarino, R. A., Hijazi, K., Houssen, W. E.
    Peptides, vol. 173, 171139
    Contributions to Journals: Articles

  • Homemade Nucleic Acid Preservation Buffer Proves Effective in Preserving the Equine Faecal Microbiota over Time at Ambient Temperatures

    Ward, A. B., Harris, P. A., Argo, C. M., Watson, C., Neacsu, M., Russell, W. R., Ribeiro, A., Collie-Duguid, E., Heidari, Z., Morrison, P. K.
    Animals, vol. 13, no. 19, 3107
    Contributions to Journals: Articles

  • Effect of feed concentration and residence time on anaerobic fermentation in CSTR and SBR to produce short-chain organic acids

    Simonettia, S., Collie-Duguid, E., Fernandez Martin, C., Louis, P., Pu, J., Smith, E., Dionisi, D.
    Journal of Environmental Chemical Engineering, vol. 11, no. 5, 110461
    Contributions to Journals: Articles

  • Effect of sampling and storage conditions upon equine fecal microbial community

    Ward, A., Harris, P., Argo, C., Watson, C., Neacsu, M., Russell, W., Ribeiro, A., Collie-Duguid, E., Heidari, Z., Morrison, P.
    Chapters in Books, Reports and Conference Proceedings: Conference Proceedings

  • Taxonomy of fibroblasts and progenitors in the synovial joint at single-cell resolution

    Collins, F., Roelofs, A., Symons, R., Kania, K., Campbell, E., Collie-Duguid, E., Riemen, A., Clark, S., De Bari, C.
    Annals of the Rheumatic Diseases, vol. 82, no. 3, pp. 428-437
    Contributions to Journals: Articles

  • β-glucan is a major growth substrate for human gut bacteria related to Coprococcus eutactus

    Alessi, A. M., Gray, V., Farquharson, F. M., Flores-López, A., Shaw, S., Stead, D., Wegmann, U., Shearman, C., Gasson, M., Collie-Duguid, E. S., Flint, H. J., Louis, P.
    Environmental Microbiology, vol. 22, no. 6, pp. 2150-2164
    Contributions to Journals: Articles

  • VGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myogenesis in skeletal muscle

    Figeac, N., Mohamed, A. D., Sun, C., Schönfelder, M., Matallanas, D., Garcia-Munoz, A., Missiaglia, E., Collie-Duguid, E., De Mello, V., Pobbati, A. V., Pruller, J., Jaka, O., Harridge, S. D. R., Hong, W., Shipley, J., Vargesson, N., Zammit, P. S., Wackerhage, H.
    Journal of Cell Science, vol. 132, jcs225946
    Contributions to Journals: Articles

  • Vgll3 interacts with Yap/Taz-Tead1-4-dependent gene expression in skeletal muscle

    Figeac, N., Mohamed, A. A. D., Sun, C., Schonfelder, M., Gomez, D., Garcia-Munoz, A., Missiaglia, E., Collie-Duguid, E., De Mello, V., Pobbati, A. V., Jaka, O., Harridge, S. D., Hong, W., Shipley, J., Vargesson, N., Zammit, P. S., Wackerhage, H.
    2019 Spring Padua Muscle Days, pp. 53-53
    Contributions to Journals: Abstracts

  • Formate cross-feeding and cooperative metabolic interactions revealed by transcriptomics in co-cultures of acetogenic and amylolytic human colonic bacteria

    Laverde Gomez, J. A., Mukhopadhya, I., Duncan, S. H., Louis, P., Shaw, S., Collie-Duguid, E., Crost, E., Juge, N., Flint, H. J.
    Environmental Microbiology, vol. 21, no. 1, pp. 259-271
    Contributions to Journals: Articles

  • Jaundice in newborns could be an evolutionary safeguard against death from sepsis

    Collie-Duguid, E., Hold, G., Hansen, R.
    The Conversation
    Contributions to Specialist Publications: Articles

  • Adaptive response of neonatal sepsis-derived Group B Streptococcus to bilirubin

    Hansen, R., Gibson, S., De Paiva Alves, E., Goddard, M., MacLaren, A., Karcher, A. M., Berry, S., Collie-Duguid, E. S. R., El-Omar, E., Munro, M., Hold, G. L.
    Scientific Reports, vol. 8, pp. 1-10
    Contributions to Journals: Articles

  • Common and Distinctive Functions of the Hippo Effectors Taz and Yap in Skeletal Muscle Stem Cell Function

    Sun, C., De Mello, V., Mohamed, A., Quiroga, H. P. O., Garcia-Munoz, A., Al Bloshi, A., Tremblay, A. M., von Kriegsheim, A., Collie-Duguid, E., Vargesson, N., Matallanas, D., Wackerhage, H., Zammit, P. S.
    Stem Cells, vol. 35, no. 8, pp. 1958-1972
    Contributions to Journals: Articles

  • Fine mapping of genes determining extrafusal fiber properties in murine soleus muscle

    Carroll, A., Cheng, R., Collie-Duguid, E., Meharg, C., Scholz, M., Fiering, S., Fields, J., Palmer, A., Lionikas, A.
    Physiological Genomics, vol. 49, no. 3, pp. 141-150
    Contributions to Journals: Articles

  • Regulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phopshate lyase determines chemotherapy resistance in gastroesophageal cancer

    Matula, K., Collie-Duguid, E., Murray, G., Parikh, K., Grabsch, H. I., Tan, P., Lalwani, S., Garau, R., Ong, Y., Bain, G., Dahle-Smith, A., Urquhart, G., Bielawski, J., Finnegan, M., Petty, R.
    BMC Cancer, vol. 15, 762
    Contributions to Journals: Articles

  • Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas

    Bain, G. H., Collie-Duguid, E., Murray, G. I., Gilbert, F. J., Denison, A., McKiddie, F., Ahearn, T., Fleming, I., Leeds, J., Phull, P., Park, K., Nanthakumaran, S., Grabsch, H. I., Tan, P., Welch, A., Schweiger, L., Dahle-Smith, A., Urquhart, G., Finegan, M., Matula, K. M., Petty, R. D.
    British Journal of Cancer, vol. 110, no. 6, pp. 1525-1534
    Contributions to Journals: Articles

  • Influence of resistance to 5-fluorouracil and tomudex on [18F]-FDG incorporation, glucose transport and hexokinase activity

    Law, A. A., Collie-Duguid, E. S. R., Smith, T. A. D.
    International Journal of Oncology, vol. 41, no. 1, pp. 378-382
    Contributions to Journals: Articles

  • SerpinB3, a new prognostic tool in breast cancer patients treated with neoadjuvant chemotherapy

    Collie-Duguid, E. S. R., Sweeney, K., Stewart, K. N., Miller, I. D., Smyth, E., Heys, S. D.
    Breast Cancer Research and Treatment, vol. 132, no. 3, pp. 807-818
    Contributions to Journals: Articles

  • Optimized response prediction in esophagogastric junction adenocarcinomas (EGJAc) with combination of molecular biomarkers and FDG-PET

    Petty, R. D., Bain, G., Murray, G. I., Gilbert, F., Denison, A. R., McKiddie, F., Ahearn, T., Leeds, J., Phull, P., Park, K., Welch, A., Schweiger, L. F., Collie-Duguid, E. S. R.
    Journal of Clinical Oncology, vol. 30, no. Suppl. 4, 1
    Contributions to Journals: Abstracts

  • MAGEA tumour antigens mediate platinum cytotoxicity in NSCLC

    Collie-Duguid, E. S. R., Bissett, J. D., Petty, R. D., Nicolson, M. C., Kerr, K.
    European Journal of Cancer, vol. 8, no. 7, pp. 99-100
    Contributions to Journals: Abstracts

  • SerpinB3, a biomarker of taxane benefit in breast cancer

    Collie-Duguid, E. S. R., Sweeney, K., Stewart, K. N., Miller, I. D., Heys, S. D.
    1st British Breast Cancer Research Conference, pp. 13
    Contributions to Journals: Abstracts

  • Aberdeen Microarray and PET in Optimising Oesophagogastric Cancer Response-1 (AMPETOOR-1). Preliminary Results: Preliminary Results

    Bain, G., Murray, G., Denison, A., Brooks, M., Collie-Duguid, E., McKiddie, F., Gilbert, F., El-Omar, E., Park, K., McAteer, D., Phull, P., Qadir, A., Petty, R.
    Annals of Oncology, vol. 21, pp. 43
    Contributions to Journals: Articles

  • APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling

    Petty, R. D., Samuel, L. M., Murray, G. I., MacDonald, G., O'Kelly, T., Loudon, M., Binnie, N., Aly, E., McKinlay, A., Wang, W., Gilbert, F., Semple, S., Collie-Duguid, E. S. R.
    BMC Cancer, vol. 9, pp. 434
    Contributions to Journals: Articles

  • Balancing Inflammatory, Lipid, and Xenobiotic Signaling Pathways by VSL#3, a Biotherapeutic Agent, in the Treatment of Inflammatory Bowel Disease

    Reiff, C., Delday, M., Rucklidge, G., Reid, M., Duncan, G., Wohlgemuth, S., Hoermannsperger, G., Loh, G., Blaut, M., Collie-Duguid, E., Haller, D., Kelly, D.
    Inflammatory Bowel Diseases, vol. 15, no. 11, pp. 1721-1736
    Contributions to Journals: Articles

  • Gene expression analysis of human fetal ovarian primordial follicle formation

    Fowler, P. A., Flannigan, S., Mathers, A., Gillanders, K., Lea, R. G., Wood, M. J., Maheshwari, A., Bhattacharya, S., Collie-Duguid, E. S. R., Baker, P. J., Monteiro, A., O'Shaughnessy, P. J.
    Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 4, pp. 1427-1435
    Contributions to Journals: Articles

  • Growth hormone in vascular pathology: Neovascularisation and expression of receptors is associated with cellular proliferation

    Guo, X., Goessl, E., Jin, G., Collie-Duguid, E. S., Cassidy, J., Wang, W., O'Brien, V.
    Anticancer Research, vol. 28, no. 2B, pp. 1439
    Contributions to Journals: Articles

  • Decreased [18F]fluoro-2-deoxy-d-glucose incorporation and increased glucose transport are associated with resistance to 5FU in MCF7 cells in vitro

    Smith, T. A. D., Sharma, R. I., Wang, W. G., Welch, A., Schweiger, L. F., Collie-Duguid, E. S. R.
    Nuclear Medicine and Biology, vol. 34, no. 8, pp. 955-960
    Contributions to Journals: Articles

  • Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks

    Wang, W., McLeod, H. L., Cassidy, J., Collie-Duguid, E. S. R.
    Cancer Chemotherapy and Pharmacology, vol. 59, no. 6, pp. 839-845
    Contributions to Journals: Articles

  • Cancer Therapy Prognosis and Target

    Collie-Duguid, E. S. R., Petty, R. D., Kerr, K.
    Patents: Patents

  • Pregnane X Receptor Activators Inhibit Human Hepatic Stellate Cell Trans-Differentiation in Vitro

    Haughton, E., Tucker, S. J., Marek, C., Durward, E., Leel, V. H. M. D., Bascal, Z., Monaghan, T., Koruth, M., Collie-Duguid, E. S. R., Mann, D. A., Trim, J. E., Wright, M. C.
    Gastroenterology, vol. 131, no. 1, pp. 194-209
    Contributions to Journals: Articles

  • Tumor transcriptome reveals the predictive and prognostic impact of lysosomal protease inhibitors in non-small-cell lung cancer

    Petty, R. D., Kerr, K., Murray, G. I., Nicolson, M., Rooney, P. H., Bissett, D., Collie-Duguid, E. S. R.
    Journal of Clinical Oncology, vol. 24, no. 11, pp. 1729-1744
    Contributions to Journals: Articles

  • The Rectal Adenocarcinoma Transcriptome Reveals a Novel Prognostic Biomarker and Candidate Novel Targets for Neoadjuvant Therapy (Aberdeen Microarray in Rectal Cancer Study-1; AMRECS-1)

    Collie-Duguid, E. S. R., Petty, R. D., Murray, G. I., MacDonald, G., Loudon, M., McKinley, A., O'Kelly, T., Binnie, N., Aly, E., Samuel, L.
    Colorectal Disease, vol. 8, no. S2
    Contributions to Journals: Articles

  • Gene expression profiling of clinical response in rectal adenocarcinomas reveals novel predictive biomarkers and therapeutic targets.

    Petty, R. D., Samuel, L., Murray, G. I., Loudon, M., O'Kelly, T. J., McKinley, A., MacDonald, G., Collie-Duguid, E. S. R.
    Contributions to Conferences: Abstracts

  • Global gene expression profiling of clinical response to radiotherapy and chemoradiotherapy in rectal adenocarcinoma reveals distinct and common molecular mechanisms of action.

    Petty, R. D., Samuel, L., Murray, G. I., MacDonald, G., Loudon, M., McKinley, A., O'Kelly, T. J., Collie-Duguid, E. S. R.
    Contributions to Conferences: Abstracts

  • Identification of the lysosomal programmed cell death (PCD) pathway as a critical determinant of clinical response in Non-Small Cell Lung Cancer (NSCLC).

    Petty, R. D., Kerr, K., Nicolson, M. C., Murray, G. I., Rooney, P. H., Bissett, D., Collie-Duguid, E. S. R.
    Lung Cancer, vol. 49, no. S141-142
    Contributions to Journals: Articles

  • Putative Novel Mechanisms Of Tomudex Resistance And Insight Into TS-Independent 5-Flurouracil Resistance Networks.

    Collie-Duguid, E. S. R., Cao, L., Cassidy, J., Wang, W.
    Contributions to Conferences: Abstracts

  • Rectal adenocarcinoma transcriptome profiles reveal distinct molecular effects of radiotherapy and chemoradiotherapy (Aberdeen Microarray in Rectal Cancer Study-1; AMRECS-1).

    Collie-Duguid, E. S. R., Petty, R. D., Murray, G. I., MacDonald, G., Loudon, M., McKinley, A., O'Kelly, T. J., Binnie, N., Aly, E., Samuel, L.
    Contributions to Conferences: Abstracts

  • Role of CD200 in tolerance induction: gene expression profiling of lymphoid tissues in response to intranasal antigen.

    Minas, K., Dawson, R., Collie-Duguid, E. S. R., Liversidge, J. M.
    Immunology, vol. 116, no. 13
    Contributions to Journals: Articles

  • Mechanistic and predictive profiling of 5-fluorouracil resistance in human cancer cells

    Wang, W., Cassidy, J., O'Brien, V., Ryan, K. M., Collie-Duguid, E. S. R.
    Cancer Research, vol. 64, pp. 8167-8176
    Contributions to Journals: Articles

  • Global profiling of molecular mechanisms of 5-fluorouracil, resistance in human cancer cells.

    Wang, W., Cassidy, J., Collie-Duguid, E. S. R.
    British Journal of Cancer, vol. 91, no. S1
    Contributions to Journals: Articles

  • Molecular mechanisms of platinum (Pt) based chemotherapy in non-small cell lung cancer patients (NSCLC) using microarrays

    Petty, R. D., Murray, G. I., Kerr, K., Nicolson, M. C., Bissett, D., Collie-Duguid, E. S. R.
    British Journal of Cancer, vol. 91, no. Supplement 1, pp. S14-S14
    Contributions to Journals: Abstracts

  • A molecular profile that predicts response to platinum based chemotherapy in non-small cell lung cancer (NSCLC) patients

    Petty, R. D., Murray, G. I., Kerr, K., Nicolson, M. C., Bissett, D., Collie-Duguid, E. S. R.
    British Cancer Research Meeting 2004, pp. S14-S14
    Contributions to Journals: Abstracts

  • Gene expression profiling in non-small cell lung cancer: from molecular mechanisms to clinical application

    Petty, R. D., Nicolson, M. C., Kerr, K. M., Collie-Duguid, E., Murray, G. I.
    Clinical Cancer Research, vol. 10, no. 10, pp. 3237-3248
    Contributions to Journals: Articles

  • Global analysis of molecular genetic mechanisms in anti-cancer drug chemoresistance

    Wang, W., Collie-Duguid, E. S. R., Cassidy, J.
    Contributions to Conferences: Abstracts

  • Microarrays identify prognostic profiles in colon cancer patients and potential mechanisms of 5FU chemoresistance

    Collie-Duguid, E. S. R., Murray, G. I., Stewart, D. L., Bissett, D., Cassidy, J., Samuel, L.
    British Journal of Cancer, vol. 91, pp. S12-S12
    Contributions to Journals: Articles

  • Molecular profiling identifies novel cell death pathways involved in Non-Small Cell Lung Cancer (NSCLC) chemoresistance and allows prediction of response.

    Petty, R. D., Murray, G. I., Kerr, K., Nicolson, M. C., Bissett, D., Collie-Duguid, E. S. R.
    Contributions to Conferences: Abstracts

  • Molecular profiling of response to platinum based therapy in non-small cell lung cancer (NSCLC) patients.

    Petty, R. D., Murray, G. I., Kerr, K., Nicolson, M. C., Bissett, D., Collie-Duguid, E. S. R.
    Journal of Clinical Oncology, vol. 22, no. 14, pp. 153S-2104
    Contributions to Journals: Articles

  • Molecular signatures for prognosis prediction in colon cancer patients

    Collie-Duguid, E. S. R., Murray, G. I., Stewart, D. L., Cassidy, J., Samuel, L.
    Contributions to Conferences: Abstracts

  • Gene expression profiling of apoptosis and cell cycle control in Dukes’ C colon tumours.

    Collie-Duguid, E. S. R., Stewart, D. L., Cassidy, J., Murray, G. I.
    British Journal of Cancer, vol. 88, no. S1
    Contributions to Journals: Articles

  • Molecular mechanisms of cytotoxicity and pathogenesis in non-small cell lung cancer (NSCLC) using gene expression profiling.

    Petty, R. D., Nicolson, M. C., Kerr, K., Murray, G. I., Collie-Duguid, E. S. R.
    British Journal of Cancer, vol. 88, no. S1
    Contributions to Journals: Articles

  • Cerivastatin enhances the cytotoxicity of 5-fluorouracil on chemosensitive and resistant colorectal cancer cell lines

    Wang, W., Collie-Duguid, E. S. R., Cassidy, J.
    FEBS Letters, vol. 531, no. 3, pp. 415-420
    Contributions to Journals: Articles

  • Pyrimidine Metabolism and G1/S transition in colon tumours.

    Collie-Duguid, E. S. R., McKay, J. A., Ladner, R. D., Lynch, F. J., Ross, V. G., Mcintosh, R. A., Murray, G. I., Cassidy, J.
    British Journal of Cancer, vol. 86, no. S1
    Contributions to Journals: Articles

  • Thymidine phosphorylase and dihydropyrimidine dehydrogenase protein expression in colorectal cancer

    Collie-Duguid, E. S. R., Johnston, S. J., Boyce, L., Smith, N., Cowieson, A., Cassidy, J., Murray, G. I., McLeod, H. L.
    International Journal of Cancer, vol. 94, no. 2, pp. 297-301
    Contributions to Journals: Articles

  • A clinician's guide to the polmerase chain reaction

    Collie-Duguid, E. S. R., McLeod, H.
    UroOncology, vol. 1, pp. 103-112
    Contributions to Journals: Literature Reviews

  • Cloning and initial characterization of the human DPYD gene promoter

    Collie-Duguid, E. S. R., Johnston, S. J., Powrie, R. H., Milano, G., Etienne, M. C., Rochat, B., Watson, G. C., McLeod, H. L.
    Biochemical and Biophysical Research Communications, vol. 271, pp. 28-35
    Contributions to Journals: Articles

  • Estimation of dihydropyrimidine dehydrogenase activity: Does it have a role in cancer therapy?

    Collie-Duguid, E. S. R., McLeod, H. L., Cassidy, J.
    Annals of Oncology, vol. 11, pp. 255-257
    Contributions to Journals: Editorials

  • Known variant DPYD alleles do not explain DPD deficiency in cancer patients

    Collie-Duguid, E. S. R., Etienne, M. C., Milano, G., McLeod, H. L.
    Pharmacogenetics, vol. 10, pp. 217-223
    Contributions to Journals: Articles

  • Therapeutic opportunities from tumour biology in metastatic colon cancer

    McLeod, H. L., McKay, J. A., Collie-Duguid, E. S. R., Cassidy, J.
    European Journal of Cancer, vol. 36, pp. 1706-1712
    Contributions to Journals: Articles

  • Ethnic variation in the thymidylate synthase enhancer region polymorphism among Caucasian and Asian populations

    Marsh, S., Collie-Duguid, E. S. R., Li, T., Liu, X. H., McLeod, H. L.
    Genomics, vol. 58, no. 3, pp. 310-312
    Contributions to Journals: Articles

  • Ethnic differences in thiopurine methyltransferase pharmacogenetics: evidence for allele specificity in Caucasian and Kenyan individuals

    McLeod, H. L., Pritchard, S. C., Githang'a, J., Indalo, A., Ameyaw, M. M., Powrie, R. H., Booth, L., Collie-Duguid, E. S. R.
    Pharmacogenetics, vol. 9, pp. 773-776
    Contributions to Journals: Articles

  • The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations

    Collie-Duguid, E. S. R., Pritchard, S. C., Powrie, R. H., Sludden, J., Collier, D. A., Li, T., McLeod, H. L.
    Pharmacogenetics, vol. 9, pp. 37-42
    Contributions to Journals: Articles

  • Thiopurine methyltransferase alleles in British and Ghanaian populations

    Ameyaw, M. M., Collie-Duguid, E. S. R., Powrie, R. H., Ofori-Adjei, D., McLeod, H. L.
    Human Molecular Genetics, vol. 8, pp. 367-370
    Contributions to Journals: Articles

  • Thiopurine Methyltransferase Genotype Predicts Therapy-Limiting Severe Toxicity from Azathioprine

    Black, A., McLeod, H., Capell, H., Powrie, R., Matowe, L., Pritchard, S. C., Collie-Duguid, E. S. R., Reid, D. M.
    Annals of Internal Medicine, vol. 129, no. 9, pp. 716-718
    Contributions to Journals: Articles

  • Nomenclature for human DPYD alleles

    McLeod, H. L., Collie-Duguid, E. S. R., Vreken, P., Johnson, M. R., Wei, X., Sapone, A., Diasio, R. B., Fernandez-Salguero, P., van Kuilenberg, A. B. P., van Gennip, A. H., Gonzalez, F. J.
    Pharmacogenetics, vol. 8, pp. 455-459
    Contributions to Journals: Articles

Refine

Chapters in Books, Reports and Conference Proceedings

Contributions to Conferences

Contributions to Journals

Contributions to Specialist Publications

Patents

Update